Sign In
Buy HOLX
$76.01
+0 (+0%)
At Close: Jun 03, 2026
Arrowpoint Investment Partners Singapore Pte. Ltd. Takes $576,000 Position in Hologic, Inc. $HOLX
03:49am, Saturday, 14'th Mar 2026
Arrowpoint Investment Partners Singapore Pte. Ltd. bought a new stake in Hologic, Inc. (NASDAQ: HOLX) in the undefined quarter, according to the company in its most recent filing with the Securities a
What Drives Hologic's GYN Surgical Strength in a Competitive Market?
09:40am, Tuesday, 10'th Mar 2026
HOLX expands its GYN Surgical reach with MyoSure, NovaSure and Gynesonics boost as the global women's health devices market grows and minimally invasive demand rises.
Here is What to Know Beyond Why Hologic, Inc. (HOLX) is a Trending Stock
10:00am, Monday, 09'th Mar 2026
Hologic (HOLX) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Hologic's Diagnostics Strength in Focus: Is More Upside Ahead?
10:55am, Friday, 06'th Mar 2026
HOLX's Diagnostics unit faces COVID-19 test declines, but Panther Fusion expansion, new assays and AI-driven Genius system support long-term growth potential.
Becker Capital Management Inc. Boosts Holdings in Hologic, Inc. $HOLX
04:35am, Tuesday, 03'rd Mar 2026
Becker Capital Management Inc. lifted its position in Hologic, Inc. (NASDAQ: HOLX) by 20.0% during the undefined quarter, according to the company in its most recent Form 13F filing with the SEC. The
111 Capital Lowers Stock Holdings in Hologic, Inc. $HOLX
03:04am, Tuesday, 03'rd Mar 2026
111 Capital cut its holdings in Hologic, Inc. (NASDAQ: HOLX) by 43.6% in the undefined quarter, according to its most recent 13F filing with the SEC. The fund owned 9,077 shares of the medical equipme
HOLX vs. GEHC: Which Women's Health Stock Should You Pick Now?
12:16pm, Thursday, 26'th Feb 2026
GE HealthCare is gaining ground with strong backlog, AI-driven imaging advances and rising service capture, while Hologic's buyout caps near-term upside.
Is Trending Stock Hologic, Inc. (HOLX) a Buy Now?
10:00am, Tuesday, 24'th Feb 2026
Recently, Zacks.com users have been paying close attention to Hologic (HOLX). This makes it worthwhile to examine what the stock has in store.
Citigroup Inc. Trims Position in Hologic, Inc. $HOLX
04:02am, Monday, 23'rd Feb 2026
Citigroup Inc. decreased its holdings in shares of Hologic, Inc. (NASDAQ: HOLX) by 13.0% in the undefined quarter, according to its most recent Form 13F filing with the SEC. The firm owned 1,136,662 s
Hologic (NASDAQ:HOLX) Hits New 52-Week High – Here’s Why
04:36am, Sunday, 22'nd Feb 2026
Hologic, Inc. (NASDAQ: HOLX - Get Free Report)'s share price reached a new 52-week high on Friday. The stock traded as high as $75.39 and last traded at $75.3550, with a volume of 703846 shares tradin
Joel Greenblatt's Strategic Moves: A Closer Look at State Street SPDR S&P 500 ETF Trust
02:01pm, Wednesday, 18'th Feb 2026
Insights from the Fourth Quarter 2025 13F Filing Joel Greenblatt (Trades, Portfolio) recently submitted the 13F filing for the fourth quarter of 2025, providin
How to Play Hologic Stock Post Q1 Earnings and Progress on Buyout?
10:46am, Monday, 16'th Feb 2026
HOLX's $18.3B Blackstone-TPG buyout nears close after Q1 miss. With shares near a $76 cash offer, the upside for HOLX investors looks dim.
Is Most-Watched Stock Hologic, Inc. (HOLX) Worth Betting on Now?
10:01am, Friday, 13'th Feb 2026
Hologic (HOLX) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Twin Capital Management Inc. Cuts Position in Hologic, Inc. $HOLX
03:22am, Monday, 09'th Feb 2026
Twin Capital Management Inc. decreased its position in Hologic, Inc. (NASDAQ: HOLX) by 77.5% during the undefined quarter, according to the company in its most recent disclosure with the Securities an
Hologic Receives FDA Approval for Aptima® HPV Assay Primary Screening Option, Expanding Cervical Health Portfolio
08:15am, Wednesday, 04'th Feb 2026
MARLBOROUGH, Mass.--(BUSINESS WIRE)---- $HOLX #FDA--Hologic Receives FDA Approval for Aptima® HPV Assay Primary Screening Option, Expanding Cervical Health Portfolio.
